Commitment to Transparency

Although we are clearly invested in bringing new and improved pharmacological treatments to market, our policy is to champion a broad scope of education and improvement initiatives. Any support provided is in strict adherence to legislation, the Irish Pharmaceutical Healthcare Association (IPHA) Code of Practice for the Pharmaceutical Industry and A.Menarini’s internal policies. All support granted is subject to stringent internal audit to ensure compliance with these requirements and published appropriately.

TRANSFER OF VALUE

The donations and grants outlined here constitute payments referred to as transfers of value (ToV). Under the EFPIA disclosure code and IPHA Code of Practice, member pharmaceutical companies are required to disclose ToVs (direct and indirect) made to HCPs and HCOs annually on the IPHA website www.transferofvalue.ie

With effect from 1 January 2022, A.Menarini Ireland will use legitimate interests (rather than written consent) as the legal basis for processing and disclosing ToV data under the applicable data protection legislation (the EU General Data Protection Regulation, as supplemented in Ireland by the Irish Data Protection Act 1988 and 2003).

The publishing of ToV data on an individual named basis serves important legitimate interests, including:

  • Demonstrating transparency in relation to the pharmaceutical industry’s relationships with HCPs
  • Promoting a culture of integrity of transactions between pharmaceutical companies and HCPs
  • Decreasing any perception of influence on HCPs by the pharmaceutical industry
  • Instilling public and patient confidence in the integrity and independence of HCPs

If you decide to apply for support, your details will be stored on our database (or those of other affiliates) and shared with the IPHA to be used for publicly reporting payments or other transfers of value made by us to you as required by our industry Code of Practice. Further information on the disclosure of ToV can be found on the website www.transferofvalue.ie

More specifically, we may collect, process and disclose data including name, principal practice address and total value of any direct or indirect transfers of value for the benefit of you in the relevant reporting period. Such disclosure will be in accordance with our Privacy Notice which can be found here and our legitimate interest. You can exercise your rights under our privacy policy by contacting ireland@menarini.ie

In disclosing such personal data to the IPHA to be made publicly available on the website www.transferofvalue.ie, the IPHA will be an independent data controller in respect of such data. The IPHA’s privacy notice is available at www.ipha.ie.

Quality first


Quality: point of departure and arrival for our drugs.

READ MORE »

Menarini in the world

The Menarini Group has companies located almost all over the world.

READ MORE »

Innovation & Research

Constant commitment to new drug research.

READ MORE »

Our values

 

10 core values have influenced the progress of our group.

READ MORE »